Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/27/2003US20030059429 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/27/2003US20030059428 Treatment of autoimmune diseases
03/27/2003US20030059425 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
03/27/2003US20030059424 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059421 DNA encoding the baboon and cynomolgus macaque prostoglandin E2 receptor EP4 subtype
03/27/2003US20030059420 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome
03/27/2003US20030059419 Identification of novel substrate I-TRAF of IKK-i kinase
03/27/2003US20030059413 For production of recombinant transduced stem/progenitor cells
03/27/2003US20030059412 Fot treatment of disorders of bone cartilage or lung defect (such as osteoporosis and cycstic fibrosis) via transfection comprising herpes thymidine kinase gene
03/27/2003US20030059403 Phaseolamin compositions and methods for using the same
03/27/2003US20030059402 Aquespheres, their preparation and uses thereof
03/27/2003US20030059376 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
03/27/2003US20030058406 Method for refracting and dispensing electro-active spectacles
03/27/2003CA2492826A1 Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
03/27/2003CA2486545A1 Peptides capable of modulating immune response
03/27/2003CA2463935A1 Methods for treating multiple sclerosis
03/27/2003CA2462396A1 Treatment of sepsis with tafi
03/27/2003CA2461176A1 Treatment of central nervous system disorders by use of pdgf or vegf
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460719A1 Igf-binding protein-derived peptide or small molecule
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460646A1 Antibacterial macrocycles
03/27/2003CA2460620A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003CA2460544A1 Anti-inflammatory agent
03/27/2003CA2460537A1 Compositions for appetite control and related methods
03/27/2003CA2460334A1 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2003CA2460321A1 Chemokines as adjuvants of immune response
03/27/2003CA2460184A1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
03/27/2003CA2460125A1 Novel compounds and compositions as cathepsin inhibitors
03/27/2003CA2460098A1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
03/27/2003CA2460076A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459137A1 Receptors and membrane-associated proteins
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2457563A1 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2425784A1 Diagnostic markers for ischemia
03/27/2003CA2357987A1 Genetic sequence related to bone diseases
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1296138A1 Use of disease-associated gene
03/26/2003EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
03/26/2003EP1295943A1 Polypeptides having activity of stimulating neutrophils
03/26/2003EP1295939A1 Insulin-like growth factor binding protein
03/26/2003EP1295938A1 Corrected sequence of the hGH-V gene and an allelic variant
03/26/2003EP1295897A1 DNA encoding the chimpanzee prostaglandin E2 receptor EP4 subtype
03/26/2003EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby
03/26/2003EP1295895A1 Peptides and Protins binding to glu-pro motifs, therapeutical compositions containing them and their applications
03/26/2003EP1295605A2 Method of increasing bone toughness and stiffness and reducing fractures
03/26/2003EP1295604A1 Preventives and remedies for diseases in association with demyelination
03/26/2003EP1295597A1 Antitumour compositions containing taxan derivatives
03/26/2003EP1295535A2 Phaseolamin compositions and methods for using the same
03/26/2003EP1295230A1 Method and system for foreign exchange price procurement and automated hedging
03/26/2003EP1295127A2 Inter-alpha-trypsin as a marker for sepsis
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294921A1 Transgenically produced platelet derived growth factor
03/26/2003EP1294918A2 Replication deficient adenoviral tnf vector
03/26/2003EP1294910A2 Protein glycosylation modification in pichia pastoris
03/26/2003EP1294903A2 Regulation of human transmembrane serine protease
03/26/2003EP1294896A2 13295 novel protein kinase molecules and uses therefor
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294893A2 Modification of hepatitis b core antigen
03/26/2003EP1294891A2 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof
03/26/2003EP1294890A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
03/26/2003EP1294889A2 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
03/26/2003EP1294887A1 Insulin homolog polypeptide zins4
03/26/2003EP1294885A2 B7-like molecules and uses thereof
03/26/2003EP1294884A2 Secretion and trafficking molecules
03/26/2003EP1294883A2 Human extracellular matrix (ecm)-related tumor marker
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294881A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier
03/26/2003EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof
03/26/2003EP1294877A2 Cgi-69 compositions and methods of use
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294875A2 55p4h4: gene expressed in various cancers
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294873A1 Tumour suppressor and uses thereof
03/26/2003EP1294872A1 Human trp-like calcium channel protein-2 (tlcc-2)
03/26/2003EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
03/26/2003EP1294868A2 Adenylyl and guanylyl cyclases
03/26/2003EP1294866A2 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
03/26/2003EP1294864A2 Mutated furin polypeptides having improved characteristics
03/26/2003EP1294849A1 Micro-organisms active in the digestive environment
03/26/2003EP1294771A2 IMMUNIZATION OF DAIRY CATTLE WITH CHIMERIC GAPC PROTEIN AGAINST i STREPTOCOCCUS /i INFECTION
03/26/2003EP1294768A1 Mutations in spink5 responsible for netherton's syndrome and atopic diseases
03/26/2003EP1294767A1 Low oxygen affinity mutant hemoglobins
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294764A2 Human receptors
03/26/2003EP1294761A2 Method for activating peroxisome proliferator activated receptor-gamma
03/26/2003EP1294759A1 Prion-binding activity in serum and plasma determined as plasminogen and fibrinogen
03/26/2003EP1294757A2 Glucagon-like peptide-1 analogs
03/26/2003EP1294756A2 Biosynthetic oncolytic molecules and uses therefor
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294751A1 Dermacentor variabilis gaba-gated chloride channels
1 ... 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 ... 3163